Transient Ischemic Rectitis as a Potential Complication after Prostatic Artery Embolization: Case Report and Review of the Literature
- University of Sao Paulo Medical School, Division of Interventional Radiology, Department of Radiology (Brazil)
- University of Sao Paulo Medical School, Colorectal Surgery Division, Department of Gastroenterology (Brazil)
- University of Sao Paulo Medical School, Department of Urology (Brazil)
- University of Zaragoza, Division of Minimally Invasive Image Guided Surgery (Spain)
Prostatic artery embolization (PAE) is an alternative treatment for benign prostatic hyperplasia. Complications are primarily related to non-target embolization. We report a case of ischemic rectitis in a 76-year-old man with significant lower urinary tract symptoms due to benign prostatic hyperplasia, probably related to nontarget embolization. Magnetic resonance imaging revealed an 85.5-g prostate and urodynamic studies confirmed Inferior vesical obstruction. PAE was performed bilaterally. During the first 3 days of follow-up, a small amount of blood mixed in the stool was observed. Colonoscopy identified rectal ulcers at day 4, which had then disappeared by day 16 post PAE without treatment. PAE is a safe, effective procedure with a low complication rate, but interventionalists should be aware of the risk of rectal nontarget embolization.
- OSTI ID:
- 22207951
- Journal Information:
- Cardiovascular and Interventional Radiology, Vol. 36, Issue 6; Other Information: Copyright (c) 2013 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); http://www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
- Country of Publication:
- United States
- Language:
- English
Similar Records
Prostatic Tissue Elimination After Prostatic Artery Embolization (PAE): A Report of Three Cases
Clinical, Laboratorial, and Urodynamic Findings of Prostatic Artery Embolization for the Treatment of Urinary Retention Related to Benign Prostatic Hyperplasia. A Prospective Single-Center Pilot Study